GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Polarean Imaging PLC (LSE:POLX) » Definitions » ROE %

Polarean Imaging (LSE:POLX) ROE % : -90.75% (As of Jun. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Polarean Imaging ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Polarean Imaging's annualized net income for the quarter that ended in Jun. 2023 was £-11.64 Mil. Polarean Imaging's average Total Stockholders Equity over the quarter that ended in Jun. 2023 was £12.83 Mil. Therefore, Polarean Imaging's annualized ROE % for the quarter that ended in Jun. 2023 was -90.75%.

The historical rank and industry rank for Polarean Imaging's ROE % or its related term are showing as below:

LSE:POLX' s ROE % Range Over the Past 10 Years
Min: -281.64   Med: -96.85   Max: -57.49
Current: -74.54

During the past 7 years, Polarean Imaging's highest ROE % was -57.49%. The lowest was -281.64%. And the median was -96.85%.

LSE:POLX's ROE % is ranked worse than
83.73% of 805 companies
in the Medical Devices & Instruments industry
Industry Median: 0.13 vs LSE:POLX: -74.54

Polarean Imaging ROE % Historical Data

The historical data trend for Polarean Imaging's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Polarean Imaging ROE % Chart

Polarean Imaging Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
ROE %
Get a 7-Day Free Trial -98.82 -96.45 -97.25 -69.42 -57.49

Polarean Imaging Semi-Annual Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -40.01 -53.01 -50.24 -62.52 -90.75

Competitive Comparison of Polarean Imaging's ROE %

For the Medical Devices subindustry, Polarean Imaging's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Polarean Imaging's ROE % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Polarean Imaging's ROE % distribution charts can be found below:

* The bar in red indicates where Polarean Imaging's ROE % falls into.



Polarean Imaging ROE % Calculation

Polarean Imaging's annualized ROE % for the fiscal year that ended in Dec. 2022 is calculated as

ROE %=Net Income (A: Dec. 2022 )/( (Total Stockholders Equity (A: Dec. 2021 )+Total Stockholders Equity (A: Dec. 2022 ))/ count )
=-11.417/( (23.867+15.849)/ 2 )
=-11.417/19.858
=-57.49 %

Polarean Imaging's annualized ROE % for the quarter that ended in Jun. 2023 is calculated as

ROE %=Net Income (Q: Jun. 2023 )/( (Total Stockholders Equity (Q: Dec. 2022 )+Total Stockholders Equity (Q: Jun. 2023 ))/ count )
=-11.644/( (15.849+9.814)/ 2 )
=-11.644/12.8315
=-90.75 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is two times the semi-annual (Jun. 2023) net income data. ROE % is displayed in the 30-year financial page.


Polarean Imaging  (LSE:POLX) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Jun. 2023 )
=Net Income/Total Stockholders Equity
=-11.644/12.8315
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-11.644 / 0.224)*(0.224 / 15.4685)*(15.4685 / 12.8315)
=Net Margin %*Asset Turnover*Equity Multiplier
=-5198.21 %*0.0145*1.2055
=ROA %*Equity Multiplier
=-75.37 %*1.2055
=-90.75 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Jun. 2023 )
=Net Income/Total Stockholders Equity
=-11.644/12.8315
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (-11.644 / -11.644) * (-11.644 / -12.044) * (-12.044 / 0.224) * (0.224 / 15.4685) * (15.4685 / 12.8315)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 1 * 0.9668 * -5376.79 % * 0.0145 * 1.2055
=-90.75 %

Note: The net income data used here is two times the semi-annual (Jun. 2023) net income data. The Revenue data used here is two times the semi-annual (Jun. 2023) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Polarean Imaging ROE % Related Terms

Thank you for viewing the detailed overview of Polarean Imaging's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Polarean Imaging (LSE:POLX) Business Description

Traded in Other Exchanges
Address
27-28 Eastcastle Street, London, GBR, W1W 8DH
Polarean Imaging PLC designs and manufactures medical drug-device combination companies operating in the high-resolution medical imaging market. Its only operating segment being the development and commercialization of gas polariser devices and ancillary instruments. Geographically, it derives most of the revenue from the United States of America and also has a presence in Canada and the United Kingdom. The company generates revenue from products and services such as Polarisers, Parts and Upgrades, Service and other revenue. Its product portfolio includes 9820 129Xe Hyperpolarizer, 9800 129Xe Hyperpolarizer, Polarean 3777 129Xe Hyperpolarizer Upgrade Module, Polarean 2881 Polarization Measurement Station, and others.

Polarean Imaging (LSE:POLX) Headlines

No Headlines